Who are Selinexol and Dexamethasone's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/selinexol-and-dexamethasone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Selinexol and Dexamethasone — Competitive Intelligence Brief

Selinexol and Dexamethasone (Selinexol and Dexamethasone) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: XPO1 inhibitor (SINE compound) combined with corticosteroid. Area: Oncology.

phase 3 XPO1 inhibitor (SINE compound) combined with corticosteroid XPO1 (Exportin-1) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Selinexol and Dexamethasone (Selinexol and Dexamethasone) — Beijing Friendship Hospital. Selinexol inhibits nuclear export of tumor suppressor proteins by blocking XPO1, while dexamethasone provides immunosuppressive and anti-inflammatory effects to enhance tolerability.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Selinexol and Dexamethasone TARGET	Selinexol and Dexamethasone	Beijing Friendship Hospital	phase 3	XPO1 inhibitor (SINE compound) combined with corticosteroid	XPO1 (Exportin-1)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (XPO1 inhibitor (SINE compound) combined with corticosteroid class)

Beijing Friendship Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Selinexol and Dexamethasone — Competitive Intelligence Brief. https://druglandscape.com/ci/selinexol-and-dexamethasone. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab